← Back to headlines
Goldman Sachs Updates Pfizer Stock Forecast
Goldman Sachs has revised its stock forecast for pharmaceutical giant Pfizer, reflecting new market analysis.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
